Cancer Treatment Holdings, Inc.
CTHZ
OTC PK
| 02/28/2003 | 11/30/2002 | 08/31/2002 | 05/31/2002 | 02/28/2002 | |
|---|---|---|---|---|---|
| Net Income | -218.90% | -83.47% | -111.08% | -70.26% | -16.67% |
| Total Depreciation and Amortization | 0.00% | 5.03% | 15.34% | 43.51% | 60.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,619.15% | -100.00% | -123.43% | -100.00% | -77.40% |
| Change in Net Operating Assets | 164.32% | 498.45% | 140.56% | 238.51% | -133.09% |
| Cash from Operations | -133.36% | -19.47% | -120.71% | -57.23% | -493.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,272.26% | -- | -- | -- | 80.87% |
| Cash from Investing | -2,272.26% | -- | -- | -- | -176.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.73% | -7.77% | -394.76% | -150.56% | -1,506.30% |
